Randomized, double-masked, sham-controlled trial of efficacy and safety of quantum molecular resonance for treating meibomian gland dysfunction
The QMR device was effective for MGD treatment, with improvements in meibum quality, corneal/conjunctival staining, telangiectatic vessels, MGPG, superior and inferior lid meiboscale, and decreased OSDI score, lid margin thickening grade, and tear IL-6 level.
Authors
- Yuda Chongpison (ORCID: https://orcid.org/0000-0001-6690-4123)
- Wiyada Quanchareonsap
- Ngamjit Kasetsuwan (ORCID: https://orcid.org/0000-0003-1926-4666)
- Lita Uthaithammarat (ORCID: https://orcid.org/0000-0003-2111-1271)
- Usanee Reinprayoon (ORCID: https://orcid.org/0000-0002-3660-3538)
- Paphaphat Dissaneevate
Institutions
- Chulalongkorn University (TH)
- King Chulalongkorn Memorial Hospital (TH)
Publication Details
- Journal
- Eye
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1038/s41433-025-03890-3
- Citations
- 1
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- King Chulalongkorn Memorial Hospital
- Chulalongkorn University
- Faculty of Medicine, Chulalongkorn University